SBIR/STTR Match Program
CSFA Number: 420-35-2382
STATE AGENCY INFORMATION
Agency Name
Department Of Commerce And Economic Opportunity (420)
Agency Contact
PROGRAM INFORMATION
Short Description
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) are competitive federal grant programs that provide funding opportunities for small businesses to perform research and development (R&D) on technology of interest to federal agencies. Both projects provide funding to explore the potential of high-tech products and encourage commercialization of those products.
This program would provide a state match to companies that have received awards through the SBIR and STTR grant programs.
Federal Authorization
N/A
Illinois Statue Authorization
This program is utilizing state funds appropriated by the Illinois General Assembly as indicated in P.A. 101-0007 to the Department of Commerce and Economic Opportunity. These grants are being issued under authority granted to the Department of Commerce and Economic Opportunity in 20 ILCS 605/55.
Illinois Administrative Rules Authorization
N/A
Objective
SBIR and STTR grants are rewarded to companies that have identified a high tech innovation that may have commercial potential. The goal of this state matching program is to increase the amount of viable, innovative products developed at Illinois small businesses. Additional grant funds at the crucial early period during development of these products will provide more "runway" for small, innovative businesses in Illinois to get their products to market.
Eligible Applicants
For-Profit Organizations; Small Businesses;
Applicant Eligibility
N/A
Beneficiary Eligibility
N/A
Types of Assistance
Formula Grants
Subject / Service Area
Economic Development
Credentials / Documentation
N/A
Preapplication Coordination
N/A
Application Procedures
N/A
Criteria Selecting Proposals
N/A
Range of Approval or Disapproval Time
N/A
Appeals
The Merit Based Review process is subject to appeal. However, competitive grant appeals are limited to the evaluation process. Evaluation scores may not be protested. Only the evaluation process is subject to appeal. The appeal must be submitted in writing to the Department within 14 calendar days from the date of the denial letter. The written appeal shall include the name and address of the appealing party, the identification of the grant and a statement of reasons for the appeal. To file an appeal, applicants must submit the appeal in writing and in accordance with the Merit-Based Application Review Appeals Process listed on the Grant Opportunities page of the DCEO website: https://www2.illinois.gov/dceo/AboutDCEO/GrantOpportunities/Pages/MeritAppReview.aspx.
Uses and Restrictions
Funds may be used for expenditures to perform research and development and other expenses related to commercialization of the products for which the company has received a federal SBIR or STTR grant.
Reports
Standard GATA reporting (performance, financial, and audits if appropriate)
Account Identification
Various
Range and Average of Financial Assistance
Various
Program Accomplishments
N/A
Regulations, Guidelines, and Literature
None.
Regional or Local Assistance Location
N/A
Headquarters Office
555 W Monroe St, 12th Floor Chicago, IL 60661, 1011 S 2nd St Springfield, IL 62704, 1020 S Spring St Springfield, IL 62704
Program Website
https://dceo.illinois.gov/whyillinois/sbir-sttr-phase1.html
Published Date
10/19/2021
FUNDING INFORMATION
Funding By Fiscal Year
FY 2020 : $1,500,000
FY 2022 : $1
FY 2023 : $5,000,000
FY 2024 : $1
FY 2026 : $6,500,000
Federal Funding
None
Notice of Funding Opportunities
| Agency ID | Award Range | Application Range |
TOP 5 ACTIVE AWARDS
| Agency ID | Grantee Name | Start Date | End Date | Amount |
| 23-322003 | Insigna, Inc. | 01/01/2023 | 06/30/2026 | 50,000 |
| 23-322016 | Energao | 01/01/2023 | 06/30/2026 | 50,000 |
| 23-322017 | Mattiq, Inc. | 05/01/2025 | 04/30/2026 | 50,000 |
| 23-322020 | VISO Therapeutics Inc. | 01/01/2023 | 06/30/2026 | 50,000 |
| 23-322035 | CLEARVOYA, LLC | 07/01/2023 | 06/30/2026 | 50,000 |